In addition, tumor cells can evade immune surveillance by several pathways, e.g., expressing immune checkpoint molecules (such as PD-L1), resulting in depression of T cell activity or recruiting immunosuppressive cells (such as regulatory T cells). This evidence concerns the gene CD274 and neoplasm.